Literature DB >> 28340544

Understanding Challenges, Strategies, and the Role of Support Networks in Medication Self-management Among Patients With Type 2 Diabetes.

Gerda Bernhard1, Dominik Ose1,2, Ines Baudendistel1, Hanna M Seidling3,4, Marion Stützle3,4, Joachim Szecsenyi1, Michel Wensing1, Cornelia Mahler1.   

Abstract

Purpose The purpose of this qualitative study was to investigate the challenges and strategies of patients with type 2 diabetes mellitus (T2DM) regarding daily management of their medication regimen focusing on the role of their support networks. Methods A purposeful sample of 25 patients with T2DM was recruited from local self-help groups, general practitioner practices, and a university hospital in southwestern Germany. Four semi-structured focus groups were conducted to identify the challenges patients experienced, the strategies they used, and their collaboration with support networks to assist them in self-managing their medication regimen. Sessions were audio- and video-recorded, fully transcribed, and subjected to computer-aided qualitative content analysis, guided by the Self- and Family Management Framework (SFMF). Results Patients with T2DM experienced numerous challenges affecting medication self-management arising from their personal situation, health status and resources, characteristics of their regimen, and how health care is currently organized. Patients' self-initiated strategies included activating health care, community, social, and online resources; taking ownership of medication-related needs; and integrating medication-taking into daily life. Patients drew on self-help groups, family, and friends to discuss concerns regarding medication safety and receive experience-based information and advice for navigating within the health care system as well as practical hands-on support with daily medication self-management. Conclusions Understanding the challenges and building on strategies patients with T2DM devised help diabetes educators to better address patients' needs and priorities and guide patient-centered interventions to support patients' self-management activities. Community and social support networks operating in patients' lives need to be engaged in the self-management support.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28340544     DOI: 10.1177/0145721717697243

Source DB:  PubMed          Journal:  Diabetes Educ        ISSN: 0145-7217            Impact factor:   2.140


  5 in total

1.  Care management intervention to strengthen self-care of multimorbid patients with type 2 diabetes in a German primary care network: A randomized controlled trial.

Authors:  Dominik Ose; Martina Kamradt; Marion Kiel; Tobias Freund; Werner Besier; Manfred Mayer; Johannes Krisam; Michel Wensing; Hans-Joachim Salize; Joachim Szecsenyi
Journal:  PLoS One       Date:  2019-06-12       Impact factor: 3.240

2.  An Electronic Medication Module to Improve Health Literacy in Patients With Type 2 Diabetes Mellitus: Pilot Randomized Controlled Trial.

Authors:  Hanna Marita Seidling; Cornelia Mahler; Beate Strauß; Aline Weis; Marion Stützle; Johannes Krisam; Joachim Szecsenyi; Walter Emil Haefeli
Journal:  JMIR Form Res       Date:  2020-04-28

3.  The Weakness of Will: The Role of Free Will in Treatment Adherence.

Authors:  Fisseha Zewdu Amdie; Monakshi Sawhney; Kevin Woo
Journal:  Patient Prefer Adherence       Date:  2022-04-29       Impact factor: 2.314

4.  Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements.

Authors:  Gerda Bernhard; Cornelia Mahler; Hanna Marita Seidling; Marion Stützle; Dominik Ose; Ines Baudendistel; Michel Wensing; Joachim Szecsenyi
Journal:  J Med Internet Res       Date:  2018-03-27       Impact factor: 5.428

5.  Patient-perceived service needs and health care utilization in people with type 2 diabetes: A multicenter cross-sectional study.

Authors:  Yunxia Ni; Suzhen Liu; Jiping Li; Simin Li; Ting Dong
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.